1. MRI findings and pathological features of occult breast cancer
Junjie ZHANG ; Xiaotang YANG ; Xiaosong DU ; Jianxin ZHANG ; Lina HOU ; Jinliang NIU
Chinese Journal of Oncology 2018;40(1):40-45
		                        		
		                        			 Objective:
		                        			To investigate the magnetic resonance imaging (MRI) findings and clinicopathological features of primary lesions in patients with occult breast cancer (OBC).
		                        		
		                        			Methods:
		                        			The imaging reports from the Breast Imaging Reporting and Data System in 2013 were retrospectively analyzed to investigate the morphology and the time signal intensity curve (TIC) of breast lesions in patients with OBC. The clinical and pathological characteristics of these patients were also included.
		                        		
		                        			Results:
		                        			A total of 34 patients were enrolled. Among these patients, 24 patients underwent modified radical mastectomy and 18 of them had primary breast carcinoma in pathological sections. MRI detected 17 cases of primary lesions, including six masse lesions with a diameter of 0.6-1.2 cm (average 0.9 cm), and 11 non-mass lesions with four linear distributions, three segmental distributions, three focal distributions, and one regions distribution. Five patients had TIC typeⅠprimary lesions, ten had TIC type Ⅱ primary lesions, and two had TIC type Ⅲ primary lesions. Among all 34 cases, 23 of them had complete results of immunohistochemistry: 11 estrogen receptor (ER) positive lesions (47.8%), tenprogesterone receptor (PR) positive lesions (43.5%), seven human epidermal growth factor receptor 2 (HER-2) positive lesions (30.4%), and 20high expression(>14%) of Ki-67 (87.0%). The proportion of type luminal A was 4.3%, type luminal B was 43.5%, triple negative breast cancer (TNBC) was 30.4%, and HER-2 over expression accounted for 21.7%.
		                        		
		                        			Conclusions
		                        			The primary lesions of OBC usually manifested as small mass lesions, or focal, linear or segmental distribution of non-mass lesions. The positive rate of ER and PR was low, but the positive rate of HER-2 and the proliferation index of Ki-67 was high. Type luminal B is the most common molecular subtype. 
		                        		
		                        		
		                        		
		                        	
2.MRI findings and pathological features of occult breast cancer
Junjie ZHANG ; Xiaotang YANG ; Xiaosong DU ; Jianxin ZHANG ; Lina HOU ; Jinliang NIU
Chinese Journal of Oncology 2018;40(1):40-45
		                        		
		                        			
		                        			Objective To investigate the magnetic resonance imaging ( MRI ) findings and clinicopathological features of primary lesions in patients with occult breast cancer ( OBC) . Methods The imaging reports from the Breast Imaging Reporting and Data System in 2013 were retrospectively analyzed to investigate the morphology and the time signal intensity curve ( TIC) of breast lesions in patients with OBC. The clinical and pathological characteristics of these patients were also included. Results A total of 34 patients were enrolled. Among these patients, 24 patients underwent modified radical mastectomy and 18 of them had primary breast carcinoma in pathological sections. MRI detected 17 cases of primary lesions, including six masse lesions with a diameter of 0.6?1.2 cm ( average 0.9 cm) , and 11 non?mass lesions with four linear distributions, three segmental distributions, three focal distributions, and one regions distribution. Five patients had TIC typeⅠprimary lesions, ten had TIC typeⅡprimary lesions, and two had TIC typeⅢprimary lesions. Among all 34 cases, 23 of them had complete results of immunohistochemistry:11 estrogen receptor (ER) positive lesions (47.8%), tenprogesterone receptor (PR) positive lesions (43.5%), seven human epidermal growth factor receptor 2 (HER?2) positive lesions (30.4%), and 20high expression(>14%) of Ki?67 (87.0%). The proportion of type luminal A was 4.3%, type luminal B was 43.5%, triple negative breast cancer ( TNBC) was 30.4%, and HER?2 over expression accounted for 21.7%. Conclusions The primary lesions of OBC usually manifested as small mass lesions, or focal, linear or segmental distribution of non?mass lesions. The positive rate of ER and PR was low, but the positive rate of HER?2 and the proliferation index of Ki?67 was high. Type luminal B is the most common molecular subtype.
		                        		
		                        		
		                        		
		                        	
3.MRI findings and pathological features of occult breast cancer
Junjie ZHANG ; Xiaotang YANG ; Xiaosong DU ; Jianxin ZHANG ; Lina HOU ; Jinliang NIU
Chinese Journal of Oncology 2018;40(1):40-45
		                        		
		                        			
		                        			Objective To investigate the magnetic resonance imaging ( MRI ) findings and clinicopathological features of primary lesions in patients with occult breast cancer ( OBC) . Methods The imaging reports from the Breast Imaging Reporting and Data System in 2013 were retrospectively analyzed to investigate the morphology and the time signal intensity curve ( TIC) of breast lesions in patients with OBC. The clinical and pathological characteristics of these patients were also included. Results A total of 34 patients were enrolled. Among these patients, 24 patients underwent modified radical mastectomy and 18 of them had primary breast carcinoma in pathological sections. MRI detected 17 cases of primary lesions, including six masse lesions with a diameter of 0.6?1.2 cm ( average 0.9 cm) , and 11 non?mass lesions with four linear distributions, three segmental distributions, three focal distributions, and one regions distribution. Five patients had TIC typeⅠprimary lesions, ten had TIC typeⅡprimary lesions, and two had TIC typeⅢprimary lesions. Among all 34 cases, 23 of them had complete results of immunohistochemistry:11 estrogen receptor (ER) positive lesions (47.8%), tenprogesterone receptor (PR) positive lesions (43.5%), seven human epidermal growth factor receptor 2 (HER?2) positive lesions (30.4%), and 20high expression(>14%) of Ki?67 (87.0%). The proportion of type luminal A was 4.3%, type luminal B was 43.5%, triple negative breast cancer ( TNBC) was 30.4%, and HER?2 over expression accounted for 21.7%. Conclusions The primary lesions of OBC usually manifested as small mass lesions, or focal, linear or segmental distribution of non?mass lesions. The positive rate of ER and PR was low, but the positive rate of HER?2 and the proliferation index of Ki?67 was high. Type luminal B is the most common molecular subtype.
		                        		
		                        		
		                        		
		                        	
4.Generation of Japanese Encephalitis Virus-like Particle Vaccine and Preliminary Evaluation of Its Protective Efficiency.
Yanfang ZHANG ; Ruikun DU ; Shaomei HUANG ; Tao ZHANG ; Jinliang LIU ; Bibo ZHU ; Hualin WANG ; Fei DENG ; Shengbo CAO
Chinese Journal of Virology 2016;32(2):150-155
		                        		
		                        			
		                        			The cDNA fragment of JEV prME gene was cloned into the baculovirus shuttle vector (bacmid) to construct a recombinant baculovirus vector, defined as AcBac-prME. Then the recombinant baculovirus Ac-prME was obtained by transfecting Sf9 cells with AcBac-prME. Western blot analysis and immunofluorescence results indicated that both prM and E proteins were efficiently expressed in Sf9 cells. Electron microscopy suggested that prME was assembled into JEV-VLPs. To further evaluate the potential of JEV-VLPs as vaccine, the mice were immunized with JEV-VLPs and then challenged with lethal JEV. The results of mice survival and pathological changes demonstrated that the JEV-VLPs performed complete protection against JEV-P3 strain and relieved pathological changes in the mice brain significant. This study suggest that JEV-VLPs would be a potential vaccine for Japanese encephalitis virus.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Antibodies, Viral
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Encephalitis Virus, Japanese
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Encephalitis, Japanese
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			prevention & control
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Japanese Encephalitis Vaccines
		                        			;
		                        		
		                        			administration & dosage
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Inbred BALB C
		                        			;
		                        		
		                        			Sf9 Cells
		                        			;
		                        		
		                        			Vaccination
		                        			;
		                        		
		                        			Vaccines, Virus-Like Particle
		                        			;
		                        		
		                        			administration & dosage
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Viral Envelope Proteins
		                        			;
		                        		
		                        			administration & dosage
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			
		                        		
		                        	
5.Risk factors and treatment efficiency for lung cancer patients with venous thromboembolism
Quanfang CHEN ; Wei WANG ; Xiaoying ZOU ; Zhian LING ; Yanbin WU ; Jinliang KONG ; Banghao XU ; Qinghua DU
The Journal of Practical Medicine 2014;(6):891-894
		                        		
		                        			
		                        			Objective To investigate the risk factors and treatment efficiency for lung cancer patients with venous thromboembolism (VTE). Methods Total 282 cases of lung cancer patients with VTE were enrolled into two groups , including the VTE group and the non-VTE group , for comparation analysis based on a series of clinical data. Results The occupation rate of adenocarcinoma and Ⅳ period were 65.28% and 87.50% in VTE group, respectively, higher than those of 51.43% and 75.71% in the non-VTE group. The increased rate of blood viscosity and d-dimer respectively were 65.28% and 70.83%, higher than those of 51.43% and 56.67% in the non-VTE group, with significant differences (P < 0.05, respectively). Result of logistic regression analysis showed that tumor stage , d-dimer levels , smoking , age , and blood viscosity levels were highly correlated with venous thrombosis in patients with lung cancer, and the OR value among them was 3.802, 2.339, 5.814, 3.875 and 6.404, respectively, with significant differencees (P < 0.05, respectively). Conclusions Lung adenocarcinoma with stage Ⅳ, smoking , age and increase of blood viscosity and d-dimer were the important risk factors for VTE in patients with lung cancer chemotherapy. Timely assessment of risk factors and early anticoagulation therapy in lung cancer patients with venous thromboembolism associated with VTE can improve the treatment efficacy and reduce the complications.
		                        		
		                        		
		                        		
		                        	
6.Expression and clinical significance of 6-phosphofructo-1-kinase in nasopharyngeal carcinoma.
Shuo LI ; Zhende DU ; Jinliang GAO ; Chunsheng GAO ; Fei LI ; Qiong YANG ; Banghua LU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(6):393-395
		                        		
		                        			OBJECTIVE:
		                        			The aim of this study is to investigate the expression and clinical significance of 6-phosphofructo-1-kinase in nasopharyngeal carcinoma biopsy samples.
		                        		
		                        			METHOD:
		                        			Sixty-one biopsy samples were detected, including 41 tissues samples from patients with nasopharyngeal carcinoma and 20 tissues samples from patients with chronic nasopharyngitis as control group. 6-phosphofructo 1 kinase mRNA expression was detected by RTPCR.
		                        		
		                        			RESULT:
		                        			It was observed that the expression levels of 6 phosphofructo-1-kinase mRNA in nasopharyngeal carcinoma tissues were higher than in the chronic inflammatory tissues. And the expression levels in patients with lymph node metastasis were higher than without lymph nod metastasis.
		                        		
		                        			CONCLUSION
		                        			6-phosphofructo-1-kinase may be a marker in occurrence and metastasis of nasopharyngeal carcinoma.
		                        		
		                        		
		                        		
		                        			Biomarkers, Tumor
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Carcinoma
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lymphatic Metastasis
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Nasopharyngeal Carcinoma
		                        			;
		                        		
		                        			Nasopharyngeal Neoplasms
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Phosphofructokinase-1
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			RNA, Messenger
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
7.Combination therapy of plasma radiofrequency ablation at low temperature and nasal endoscopy for chronic na-sal sinusitis
Jinliang GAO ; Chunsheng GAO ; Shuo LI ; Di QIAN ; Zhengde DU ; Cheng LIU
Journal of Regional Anatomy and Operative Surgery 2014;(1):44-45
		                        		
		                        			
		                        			Objective To explore the curative effect of combination therapy of low-temperature plasma radiofrequency ablation and nasal endoscopy for chronic nasal sinusitis. Methods From January 2010 to January 2012,98 patients with chronic nasal sinusitis in our hospital were ramdomly divided into observation group and control group. The observation group (49 cases) received plasma radiofrequency ablation at low temperature combined nasal endoscopic treatment. The control group (49 cases) were performed only nasal endoscopic treatment. The curative effect of the 2 groups were compared. Results After 1 month and 1 year, the total effective rate of the observation group were 91. 84% and 89. 80%, the total effective rate of the control group were 77. 55% and 73. 47% respectively. To compare the total effective rate of 2 groups were compared,there were statistically significant differences(P<0. 05). Conclusion Curative effect of plasma radiofrequency ablation at low temperature and nasal endoscopy is distinct,it is worthy of being widely applied in clinic.
		                        		
		                        		
		                        		
		                        	
8.Intralesional bleomycin-A5 with dexamethasone injection under pedestal laryngoscope for huge laryngopharyngeal and laryngeal hemangiomas.
Shuo LI ; Haidi YANG ; Zhengde DU ; Jinliang GAO ; Hongwei ZHANG ; Chunsheng GAO
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2013;27(15):801-803
		                        		
		                        			OBJECTIVE:
		                        			To investigate the therapeutic effect of intralesional bleomycin-A5 with dexamethasone injection under pedestal laryngoscope for huge laryngopharyngeal and laryngeal hemangiomas.
		                        		
		                        			METHOD:
		                        			Intralesional bleomycin-A5 with dexamethasone injection under pedestal laryngoscope was performed in huge laryngopharyngeal and laryngeal hemangiomas.
		                        		
		                        			RESULT:
		                        			The injection frequencies were 3 times in 4 cases, 4 times in 3 cases, and 5 times in 9 cases. Twelve cases (75%) were cured, and 4 cases (25%) were improved.
		                        		
		                        			CONCLUSION
		                        			Intralesional bleomycin-A5 with dexamethasone injection under pedestal laryngoscope is a safe, effective and minimally invasive therapeutic method for huge laryngopharyngeal and laryngeal hemangiomas.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Bleomycin
		                        			;
		                        		
		                        			analogs & derivatives
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Dexamethasone
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hemangioma
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypopharyngeal Neoplasms
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Laryngeal Neoplasms
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Laryngoscopes
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Treatment Outcome
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
9.Analysis on content of serum monoamine neurotransmitters in macaques with anger-in-induced premenstrual syndrome and liver-qi depression syndrome.
Sheng WEI ; Jinliang HOU ; Yubin CHAO ; Xiyang DU ; Shaobo ZONG
Journal of Integrative Medicine 2012;10(8):925-31
		                        		
		                        			
		                        			To observe the changes in content of monoamine neurotransmitters in the serum of rhesus macaques, and explore the role of serum monoamine neurotransmitters in premenstrual syndrome (PMS) and liver-qi depression induced by anger-in emotion.
		                        		
		                        		
		                        		
		                        	
10.Stem cells transplantation for experimental colitis in rats
Yuyuan LI ; Yuqiang NIE ; Jieying LAI ; Jinliang DUAN ; Yaming WEI ; Yanlei DU ; Weihong SHA ; Yongjian ZHOU
Chinese Journal of Digestion 2008;28(6):364-368
		                        		
		                        			
		                        			Objective To investigate the effect of transplantation of allogeneic bone marrow hematopoietic cells(HCs)and mesenchymal stem cells(MSCs)on experimental colitis(EC)in rats.Methods The HCs and MSCs obtained from SD male rats were cultured and expanded in vitro.In experiment 1 and 2 groups,HCs were labeled with bromodeoxyuridine(BrdU)and MSCs were obtained using the tube wall attach technique,respectively.Seventy-two female rats were infused with trinitrobenzene sulfonic acid(TNBS)to induce EC models.After 24 hours,HC or MSC suspensions were injected into the rats in experimental 1(n=18)and 2(n=18)groups via caudal veins,respectively.Control animals were injected with isotonic saline.The whole colon was removed on day 7,14 and 21 after transplantation and examined histopathologically.BrdU labeled HCs were tested with immunohistochemical staining and MSCs were detected for sex-determining gene(sry)by PCR.Results EC models were successfully established.The HCs or MSCs grew rapidly in the culture suspension.On day 7,14 and 21 after transplantation,the BrdU immunoreactive cells were detected in the colon(6/6),and the positive expression of the sry gene was found in 1/6,2/6 and 3/6,respectively.No positive labeled cell was found in controls.There was no significant improvement in histopathological scores on the colon in two experimental groups compared with the controls.Conclusions Allogeneic HCs and MSCs may localize in the colon of EC models.The ability of localization is higher in HCs than MSCs.The transplantation of HCs and MSCs can not obviously improve histopathologically.
		                        		
		                        		
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail